22851 Investors following Biocon. Share this News with them.
0
Like this story, share it with millions of investors on M3
Nanomedicine is at the frontline of new drug delivery
They are shrinking our medical world, reports Business Line. Soon there will be ‘midgets’ in drugs, scans and possibly all that touches us health-wise. Drug researchers are going to unimaginably small or ‘nano’ lengths — a millionth of a millimetre or less — to create accurate disease detection, affordable cures and targeted medicine.
They are shrinking our medical world. Soon there will be 'midgets' in drugs, scans and possibly all that touches us health-wise.
Drug researchers are going to unimaginably small or 'nano' lengths - a millionth of a millimetre or less - to create accurate disease detection, affordable cures and targeted medicine.
In India, if Dabur brought the first nanotechnology-based delivery system with onco drug Nanoxel this year, Biocon says it will launch breast cancer nanodrug Abraxane, developed by Abraxis Biosciences, US, in early 2008.
Drug researchers are going to unimaginably small or 'nano' lengths - a millionth of a millimetre or less - to create accurate disease detection, affordable cures and targeted medicine. 
